Who We Are
Pharmaceutical raw materials and active pharmaceutical ingredients manufacturers
Tianming Pharmaceutical is a leading company in the research, development, production, and sales of new drugs. Specializing in chemical intermediates, pharmaceutical chemicals, and raw materials, we are trusted active pharmaceutical ingredient suppliers for antibiotics, cardiovascular, diabetes, anti-tumor, anti-aging, and antiviral drugs.
What We Do
Transforming Health with Premium Pharmaceutical Solutions
Advanced Drug R&D
Our team pioneers in discovering and developing new drugs, focusing on antibiotics, cardiovascular, diabetes, anti-tumor, anti-aging, and antiviral treatments.
High-Quality Manufacturing
We maintain rigorous quality control across all production processes, guaranteeing the highest standards for our chemical intermediates and pharmaceutical raw materials.
Comprehensive Global Distribution
We provide active pharmaceutical ingredients, technical consulting, collaborative R&D and other services to global customers to meet diverse market needs.
Our Products
Popular categories
Antiviral
Antiviral products and their intermediates (baloxavir fumarate, nafamostat mesylate, mupiravir, etc.)
Diabetes
Diabetes API and their intermediates (alogliptin, linagliptin, empagliflozin, etc.)
Anti-tumor
Anti-tumor API and their intermediates (ibrutinib, baricitinib, tofacitinib, etc.)
Cardiovascular
Cardiovascular API and their intermediates (LCZ696, AHU377 calcium salt, etc.)
What's News
Latest news at Tianming
Nifedipine vs. Amlodipine: Unraveling the Calcium Channel Blocker Showdown for Hypertension and Angina
Comparing Nifedipine & Amlodipine: Onset, duration, and side effects decoded. Demand for amlodipine intermediates? We deliver quality.
Hechi City Leaders Visit Tianming Pharmaceutical Headquarters to Discuss Innovation in Pharmaceutical Industry
Hechi Vice Mayor Chen Zhijie toured Tianming Pharmaceutical’s facilities, praising its R&D strength and the “Jinan R&D + Hechi production” model.
Orforglipron API: Chemical Insights, Applications, and Safety Considerations
This non-peptide GLP-1 receptor agonist, now in late-stage clinical trials, is redefining possibilities for diabetes and obesity treatment. Let’s unpack what makes it distinctive from both lab bench and manufacturing perspectives.